Bone Marrow Transplantation News

Professor Geoffrey Hill has been appointed director of hematopoietic stem cell transplantation at Fred Hutchinson Cancer Research Center.

HemOnc Today honored its inaugural class of Next Gen Innovators during the ASH Annual Meeting and Exposition.

ATLANTA — Patients who received autologous and allogeneic hematopoietic stem cell transplantation in their homes maintained their quality of life and had low rates of infectious complications, according to a small, phase 1 study presented at the ASH Annual Meeting and Exposition.

ATLANTA — Transplant-associated thrombotic microangiopathy may be a final common pathway for several disorders with different pathophysiologic mechanisms, according to a retrospective cohort analysis presented at the ASH Annual Meeting and Exposition.

ATLANTA —Twelve percent of adults with acute myeloid or acute lymphoblastic leukemia who received umbilical cord blood transplantation experienced graft failure, according to a large European retrospective study presented at the ASH Annual Meeting and Exposition.

ATLANTA — Long-term survivors of allogeneic bone marrow transplant who develop chronic graft-versus-host disease are three times more likely to develop multiple chronic health conditions, according to study results presented at the ASH Annual Meeting and Exposition.

ASH will present awards to former Vice President Joe Biden, as well as journalist and author Tom Brokaw, in recognition of their advocacy for biomedical research and hematology.

ASH announced the recipients of the society’s 2018 Scholar Awards.

The Leukemia & Lymphoma Society committed $46 million toward research efforts at medical institutions worldwide.

The FDA today approved letermovir tablets and injection, the first treatment indicated for cytomegalovirus prophylaxis in adults who have been exposed to cytomegalovirus and underwent an allogeneic hematopoietic stem cell transplant.